Search by Drug Name or NDC

    NDC 42291-0653-30 Olanzapine and Fluoxetine 25; 6 mg/1; mg/1 Details

    Olanzapine and Fluoxetine 25; 6 mg/1; mg/1

    Olanzapine and Fluoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is FLUOXETINE HYDROCHLORIDE; OLANZAPINE.

    Product Information

    NDC 42291-0653
    Product ID 42291-653_0e9921e5-8eea-5fe0-e063-6294a90a8765
    Associated GPIs 62995002500120
    GCN Sequence Number 053400
    GCN Sequence Number Description olanzapine/fluoxetine HCl CAPSULE 6MG-25MG ORAL
    HIC3 H7Z
    HIC3 Description SSRI-ANTIPSYCH, ATYPICAL,DOPAMINE,SEROTONIN ANTAG
    GCN 20868
    HICL Sequence Number 025800
    HICL Sequence Number Description OLANZAPINE/FLUOXETINE HCL
    Brand/Generic Generic
    Proprietary Name Olanzapine and Fluoxetine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Olanzapine and Fluoxetine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25; 6
    Active Ingredient Units mg/1; mg/1
    Substance Name FLUOXETINE HYDROCHLORIDE; OLANZAPINE
    Labeler Name AvKARE
    Pharmaceutical Class Atypical Antipsychotic [EPC], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077528
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0653-30 (42291065330)

    NDC Package Code 42291-653-30
    Billing NDC 42291065330
    Package 30 CAPSULE in 1 BOTTLE (42291-653-30)
    Marketing Start Date 2014-01-21
    NDC Exclude Flag N
    Pricing Information N/A